Sunday, March 9, 2025
40.7 F
New York

LEVIUM (Glauser Life Sciences, Inc.) Receives the MedNewsPedia Award for the Safest and Most Effective Long-Term Alternative to Xanax and Addictive Benzodiazepines for the Alleviation of Anxiety and Stress

MedNewsPedia has recognized Levium, by Glauser Life Sciences, Inc., for its safety and effectiveness as an alternative to Xanax and other addictive, potentially dangerous benzodiazepine medications. This all-natural, scientifically formulated supplement is designed to alleviate the effects of anxiety without the vexing side effects and long-term negative health consequences of benzodiazepines.

Levium, a standout anti-anxiety supplement by Los Angeles-based Glauser Life Sciences, Inc., has been named the safest and most effective long-term alternative to benzodiazepines for alleviating the effects of anxiety and stress. Digital publication MedNewsPedia announced this honor to recognize Levium’s powerful, side-effect-free impact on the widespread problem of anxiety. 

According to Fact.MR, the global market for stress relief supplementation hit $530 million in 2023. Insiders predict an annual growth rate for this market of about 6% compounded annually through 2033. By then, consumers worldwide are expected to be investing $950 million in anti-anxiety and stress supplements annually.

Levium includes a proprietary blend of ingredients, including apigenin, luteolin, resveratrol, KSM-66 ashwagandha, niacin (vitamin B3), GABA, and magnesium. These ingredients have been meticulously proportioned to target certain enzymes in the brain that are responsible for breaking down neuropeptide Y (NPY), a chemical messenger associated with resilience to stress.

Levium causes no side effects and is fast-acting. Its liquid formula uses liposome-based delivery technology to make the active ingredients absorb more readily into the cells. Levium is also safe for use in combination with other medications, including selective serotonin reuptake inhibitors (SSRI) and even benzodiazepines. Moreover, Levium is safe for long-term use.

According to Glauser Life Sciences, Inc. Founder and CEO Christopher Adams, the company developed Levium to help alleviate the anxiety epidemic plaguing modern life. “Every year,” Adams says, “some 40 million Americans present with anxiety. Levium is a safe, non-addictive alternative to compounds like benzodiazepines. Our data indicates it not only helps reduce anxiety, but that it also improves mood, protects against cognitive and memory problems, and improves sleep.”

He continues, “Ironically, one of the potential side effects of benzodiazepines is anxiety. Levium has helped thousands of people who’ve been on prescription medications a long time and can’t deal with life on them anymore. It’s helped them taper off those meds and experience life with less anxiety and no side effects.”

LEVIUM (Glauser Life Sciences, Inc.) Receives the MedNewsPedia Award for the Safest and Most Effective Long-Term Alternative to Xanax and Addictive Benzodiazepines for the Alleviation of Anxiety and Stress is an original (MedNewsPedia) article.

Levium Capsules for stress reilief

The story behind Levium

Glauser Life Sciences Founder Christopher Adams has personally experienced the debilitating effects of general anxiety disorder. His daughter also struggles with the same issue, further fueling Christopher’s personal commitment to Levium. In seeking effective solutions for his anxiety, Christopher saw the need for an all-natural solution that works but doesn’t include the dangerous side effects of pharmaceuticals.

For decades, doctors have commonly prescribed benzodiazepines, including Xanax, Valium, Ativan, Klonopin, and others, to treat anxiety, panic disorders, and insomnia. While these drugs have provided relief for many, they’ve also made life worse for countless others.

The potentially life-altering side effects of these drugs include drowsiness, dizziness, disorientation, impaired coordination and balance, memory problems, muscle weakness, blurred vision, mood swings, behavioral changes, physical dependence, and withdrawal. Long-term benzodiazepine use has even been linked to permanent declines in cognition (including dementia), motor coordination, and reaction time. It’s no wonder, then, that people are seeking safer alternatives for the treatment of stress and anxiety. The explosive growth of the anti-anxiety and stress supplementation market reflects this demand.

Founded in 2015, Glauser Life Sciences, Inc. is committed to developing revolutionary, next-generation treatments for various Central Nervous System (CNS) disorders. The company has partnered with a diverse, talented team of experts, including scientists, doctors, and business leaders. It conducts pioneering research, working toward the development of products that not only assist those in need but also help redefine the paradigm of treatment.

Levium, available in capsules and liquid form, embodies Christopher’s vision of a safe, all-natural, and effective alternative to benzodiazepines. He has experienced its effectiveness firsthand and seen the difference it’s made for his daughter. He hopes to get Levium into the hands of as many anxiety sufferers as possible so that it can make that same difference in their lives, too.

About

MedNewsPedia is a digital publication serving an audience located primarily in the United States

###

Important Note: The information contained in this article is for general informational purposes only, and should not be construed as health or medical advice, nor is it intended to diagnose, prevent, treat, or cure any disease or health condition. Before embarking on any diet, fitness regimen, or program of nutritional supplementation, it is advisable to consult your healthcare professional in order to determine its safety and probable efficacy in terms of your individual state of health.

Regarding Nutritional Supplements Or Other Non-Prescription Health Products: If any nutritional supplements or other non-prescription health products are mentioned in the foregoing article, any claims or statements made about them have not been evaluated by the U.S. Food and Drug Administration, and such nutritional supplements or other health products are not intended to diagnose, treat, cure, or prevent any disease.

Hot this week

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Topics

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Latest Cancer Treatment Breakthroughs: Advancements in Pharmacological Therapies for Better Outcomes

Cancer remains one of the most pressing health challenges globally, with millions of lives affected each year. However, the landscape of cancer treatment is continuously evolving, with groundbreaking pharmacological advancements offering new hope. The latest cancer treatment options focus on precision medicine, immunotherapy, and targeted therapies that enhance patient survival and quality of life. With recent cancer treatment breakthroughs, researchers and clinicians are increasingly optimistic about improving patient outcomes and moving closer to a cure. This article explores the newest cancer treatment advancements, including innovative drug therapies, novel treatment mechanisms, and emerging trends in oncological pharmacology.

Does Exercise Lower Cholesterol? The Science Behind Physical Activity and Heart Health

Cholesterol plays a crucial role in various physiological processes, but elevated levels, particularly of low-density lipoprotein (LDL) cholesterol, are a major risk factor for cardiovascular disease. The link between physical activity and cholesterol reduction has been extensively studied, raising the question: Does exercise lower cholesterol? Research suggests that engaging in regular physical activity can contribute significantly to improving lipid profiles, reducing cardiovascular risk, and promoting overall metabolic health. The mechanisms through which exercise impacts cholesterol levels are complex, involving enhanced lipid metabolism, increased high-density lipoprotein (HDL) production, and improved arterial function. In this article, we will examine the scientific evidence on whether exercise can lower cholesterol, explore the physiological processes involved, and discuss the best exercise strategies for optimizing cholesterol levels.

Can You Reverse Coronary Heart Disease? Understanding Risks, Treatments, and Lifestyle Interventions

Coronary heart disease (CHD) remains one of the leading causes of mortality worldwide, affecting millions of individuals each year. As the primary driver of heart attacks and other cardiovascular complications, CHD has garnered significant attention from medical professionals and researchers alike. A common question many people ask is: Can you reverse coronary heart disease? This inquiry stems from a growing interest in alternative and lifestyle-based approaches to cardiovascular health. While conventional medicine offers various treatments, emerging research suggests that lifestyle interventions, medical therapies, and dietary adjustments may play a role in reversing certain aspects of CHD. Understanding the mechanisms, risks, and available interventions can help individuals make informed decisions about their heart health.

Related Articles

Popular Categories

spot_imgspot_img